Price (delayed)
$15
Market cap
$2.49B
P/E Ratio
83.33
Dividend/share
N/A
EPS
$0.18
Enterprise value
$2.35B
Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years it has been working at the forefront of healthcare to bring vital solutions to people who
There are no recent dividends present for ACAD.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.